-
公开(公告)号:EP2753326A4
公开(公告)日:2015-04-15
申请号:EP12830073
申请日:2012-09-07
申请人: CUBIST PHARM INC
IPC分类号: A61K31/397 , A61K9/00 , A61K31/431 , A61K31/546 , A61P31/04
CPC分类号: A61K31/546 , A61K9/0019 , A61K9/007 , A61K31/431 , A61K2300/00
摘要: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.